AEP Enters Agreement With Icahn Capital
In this article:
The utility company said that Icahn Enterprises senior managing director Hunter Gary and retired executive vice president of Southern Company Gas Hank Linginfelter will join the board.
Advertisement
Recommended Stories
Bitcoin Plunges. Here’s Why and How Far Prices Could Fall.
Bitcoin sells off alongside stocks amid wider market jitters. But now the technical backdrop for cryptos is even weaker.
Barrons.com•The Secret to Passive Income Is Hiding in This Unstoppable Dividend Stock
This is one of the most reliable cash-generating companies on the stock market.
Motley Fool•Pfizer Jumps After Raising Its Outlook On The Heels Of A Big Quarterly Beat
Pfizer beat earnings views Wednesday and reported better-than-projected sales. The company raised its profit guide and Pfizer stock jumped.
Investor's Business Daily•Artificial Intelligence (AI) Isn't Going Anywhere. Here Are 3 Stocks to Buy and Hold for Decades.
These companies are behind the creation and power of AI models that are changing our world.
Motley Fool•CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist
CVS Health missed first-quarter expectations and chopped its 2024 outlook more than a dollar below Wall Street’s forecast. Shares of the health care giant plunged Wednesday morning after the company said it was still struggling with rising costs from care use in its Medicare Advantage business. Company leaders told analysts they were still dealing with rising use from outpatient care and in supplemental benefits.
Associated Press Finance•Tesla lays off executives, cuts Supercharger division
Tesla fired two key executives and trimmed hundreds of staff, gutting its Supercharger program, a leaked email shows.
Autoblog•Pfizer Stock Rises as Outlook Raised After Earnings Beat
Pfizer stock was rising Wednesday after the vaccine maker beat first-quarter earnings expectations and raised its adjusted profit outlook for the year. Pfizer reported first-quarter adjusted earnings of 82 cents a share on revenue of $14.88 billion. “We delivered strong performance in our non-Covid product portfolio in the first quarter of 2024,” Chief Executive Albert Bourla said in a press release.
Barrons.com•Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid demand
(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, and reported first-quarter results that topped Wall Street estimates on cost cuts, a smaller-than-feared drop in sales of its COVID antiviral treatment and strong sales of its pneumonia vaccine. Sales of cancer treatment Padcev, which Pfizer gained through its $43 billion deal for Seagen, also came in ahead of analysts' expectations. The Seagen deal, as well as its $4 billion cost-cutting plan, are a key part of Pfizer's post-COVID growth strategy.
Reuters•Like Realty Income? This Competitor Has an Even Better Dividend Track Record
Realty Income is the leader in the net lease REIT industry, but there's an important area where it is not No. 1.
Motley Fool•3M Is ‘Resetting’ Its Dividend. Why Its Stock Is Soaring.
3M’s quarterly earnings topped Wall Street estimates—a positive—but what the company said about its dividend should get most of the attention. Results included numbers for the recently spun off 3M healthcare business, Solventum That spin was completed on April 1. “We’re resetting the dividend post-spin,” 3M CEO Mike Roman told Barron’s. The company will target about 40% of its free cash flow as annual dividends.
Barrons.com•